Get the Stockscreener App
9.61
10.84%
0.94
Envveno Medical Corporation stock is traded at $9.61, with a volume of 8,574.
It is up +10.84% in the last 24 hours and down -19.72% over the past month.
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
See More
Previous Close:
$8.67
Open:
$8.89
24h Volume:
8,574
Relative Volume:
0.37
Market Cap:
$6.30M
Revenue:
-
Net Income/Loss:
$-24.05M
P/E Ratio:
-4.4698
EPS:
-2.15
Net Cash Flow:
$-17.78M
1W Performance:
+3.33%
1M Performance:
-19.72%
6M Performance:
-94.50%
1Y Performance:
-92.18%
1-Day Range:
$8.89
$10.21
1-Week Range:
$8.67
$10.21
52-Week Range:
$8.67
$196.70
Envveno Medical Corporation Stock (NVNO) Company Profile
Name
Envveno Medical Corporation
Sector
Industry
Phone
949-261-2900
Address
70 DOPPLER, IRVINE
Compare NVNO vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NVNO
Envveno Medical Corporation
|
9.61 | 5.68M | 0 | -24.05M | -17.78M | -2.15 |
|
ABT
Abbott Laboratories
|
113.29 | 195.21B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
377.32 | 141.28B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
98.49 | 123.60B | 35.48B | 4.64B | 5.41B | 3.5856 |
|
BSX
Boston Scientific Corp
|
76.28 | 113.14B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.98 | 45.52B | 6.07B | 1.06B | 799.60M | 1.8527 |
Envveno Medical Corporation Stock (NVNO) Latest News
enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement - Pal-Item
Fed Watch: Can enVVeno Medical Corporation maintain sales growthMarket Volume Report & Verified Chart Pattern Trade Signals - baoquankhu1.vn
enVVeno Medical Announces Reverse Stock Split - The Florida Times-Union
Strategic Investor Acquires Significant Stake in enVVeno Medical - AD HOC NEWS
Aug Analyst Calls: Is enVVeno Medical Corporation a strong candidate for buy and hold2025 Risk Factors & Short-Term High Return Ideas - baoquankhu1.vn
Head to Head Analysis: LENSAR (NASDAQ:LNSR) versus enVVeno Medical (NASDAQ:NVNO) - Defense World
enVVeno Receives Unfavorable Appeal Decision from the FDA for the VenoValve - The Northwest Florida Daily News
enVVeno Medical (NASDAQ:NVNO) to Participate in a Live Virtual Investor CEO Connect Segment - DelmarvaNow.com
enVVeno Medical Regains Nasdaq Compliance, Supports 2026 Plans - The Globe and Mail
EnVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement - News Channel Nebraska Southeast
enVVeno Medical regains Nasdaq compliance, reports $28 million cash By Investing.com - Investing.com Nigeria
enVVeno Medical regains compliance with Nasdaq minimum bid price rule - TipRanks
enVVeno Medical Regains Nasdaq Compliance - Orange County Business Journal
enVVeno Medical regains Nasdaq compliance, reports $28 million cash - Investing.com
Bank Watch: Is enVVeno Medical Corporation a strong candidate for buy and hold2025 Performance Recap & Smart Investment Allocation Tips - baoquankhu1.vn
enVVeno Medical Reports Third Quarter 2025 Financial Results and Provides Corporate Update - Green Bay Press-Gazette
Breakout Zone: Why is Pliant Therapeutics Inc stock going upJuly 2025 Macro Moves & Expert Verified Stock Movement Alerts - baoquankhu1.vn
Volume Report: Will enVVeno Medical Corporation benefit from seasonalityShort Setup & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Highs Report: Is enVVeno Medical Corporation trading at a discount2025 Support & Resistance & Long Hold Capital Preservation Tips - baoquankhu1.vn
enVVeno Medical Executes One-for-35 Reverse Stock Split - TipRanks
EnVVeno Medical announces reverse stock split; shares down 20% - MSN
enVVeno Medical announces RSS - Medical Buyer
Midday Stock Roundup: loanDepot Jumps on Trump’s Proposed Mortgage Plan - Orange County Business Journal
Do Not Use - ocbj.com
enVVeno Medical Stock Set to Reverse Split on Tuesday, January 20th (NASDAQ:NVNO) - Defense World
enVVeno Medical announces 1-for-35 reverse stock split By Investing.com - Investing.com Nigeria
enVVeno Medical Approves 1-for-35 Reverse Stock Split, Reducing Shares to 655K - Intellectia AI
enVVeno Medical announces 1-for-35 reverse stock split - Investing.com
enVVeno Medical board approves 1-for-35 reverse stock split - TipRanks
What enVVeno's 1-for-35 reverse stock split means for shareholders in 2026 - Stock Titan
Envveno Medical Corporation Stock (NVNO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):